BioPharma Diagnostic Services offers a full-suite of solutions for the pharmaceutical, biotech, and IVD industries. Each solution aligns the expertise and resources of Mayo Clinic to research projects of all sizes.
Laboratory Testing Services
Powered by Mayo Clinic Laboratories, our Laboratory Testing Services enable access to the largest clinical specialty test menu in the world including hematology, oncology, neurology, gastroenterology, and infectious diseases as well as research laboratories throughout Mayo Clinic. Capabilities include a catalog of more than 3,200 clinical tests (CAP/CLIA accredited) along with research-grade tests and sponsored testing program development.
Pharmaceutical Diagnostic Services
Our experts and services align the diagnostic expertise of Mayo Clinic to each phase of a clinical trial. Discovery and pre-clinical capabilities include access to Mayo Clinic research activities, physicians and scientists for consultation, research test development, and access to biospecimens and data. To support active clinical trials, the service matches the right testing to each aspect of the trial including access to the Mayo Clinic Laboratories' testing, clinical test development support, sponsored testing programs, and companion diagnostics development and implementation.
Diagnostic Development and Validation Services
In vitro diagnostics (IVD)-specific services bring together diagnostic company research and development activities and the diagnostic expertise of Mayo Clinic. Capabilities include access to highly annotated biospecimens and data from the Mayo Clinic practice, full validation of a new test or device in compliance with CLIA, and test development resources guided by Mayo Clinic physicians and scientists.
Biomarker Discovery and Translation Services
Facilitates industry collaborations with Mayo Clinic to identify biomarkers that can be used to indicate health or disease. Supported by a multidisciplinary team of clinicians, pathologists, molecular biologists, bioengineers, bioinformaticians, and others, the service guides the collaboration through discovery, experimental validation, preclinical validation, clinical validation, and clinical test development activities.